+28.2%
MRNA vs HAS
+43.5%
-15.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | HAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.5% | -1.9% | -2.9% |
| 7D | -10.1% | -4.8% | -5.2% | -8.5% |
| 30D | +126.7% | -5.1% | +131.9% | +130.7% |
| 3M | +184.1% | +6.4% | +177.7% | +177.0% |
| 6M | +143.3% | -5.6% | +148.9% | +145.7% |
| YTD | +359.9% | +11.0% | +348.9% | +333.2% |
| 1Y | +454.2% | +16.8% | +437.4% | +410.2% |
| All | +28.2% | +43.5% | -15.3% | -14.0% |
Cumulative growth
Daily Returns
Daily percentage return beside HAS.
Daily Out/Under-Performance
Portfolio return minus HAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling